Chargement en cours...

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?

Treatment responses to imatinib vary among patients with chronic myeloid leukemia (CML), and definitions of treatment failure and suboptimal response have been published. This article discusses monitoring and treatment of patients with CML after failure of or suboptimal response to imatinib therapy....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jabbour, Elias, Cortes, Jorge E., Kantarjian, Hagop M.
Format: Artigo
Langue:Inglês
Publié: Mayo Foundation for Medical Education and Research 2009
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2664587/
https://ncbi.nlm.nih.gov/pubmed/19181650
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!